IP Library Granted Patent US 11,963,796
Granted Patent B1
US 11,963,796 · App. 17/349,234 · Granted Apr 23, 2024

Heterogeneous integration of silicon-fabricated solid microneedle sensors and CMOS circuitry

Inventors: Joshua Windmiller (San Diego, CA); Jared Rylan Tangney (Encinitas, CA)
Assignee: Biolinq Incorporated
A61B5/685A61B5/0048A61M37/0015A61M2037/0046
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,963,796
App. No.
17/349,234
Granted
Apr 23, 2024
Kind
B1
Abstract

A skin-adorned physiological or biochemical sensing device is disclosed herein. The device preferably comprises a first substrate and a second substrate. The first substrate comprises an array of solid microneedles designed to penetrate a biological interface to access a physiological fluid or tissue. Each microneedle is capable of electrical interface with the physiological fluid or tissue. The second substrate comprises integrated circuitry designed to transduce at least one signal produced by an electrophysiological or electrochemical reaction. A sensing device is formed that is capable of interpreting the signal arising from the electrophysiological or electrochemical reaction to ascertain the level of some physiological or biochemical entity.

Claims (53)

1. A skin-adorned sensing device, comprising:

a first substrate comprising:

an anterior surface comprising an array of microneedles configured to sense an electrophysiological or electrochemical reaction within physiological fluid or tissue, wherein each microneedle of the array of microneedles comprises an addressable electrode located on a surface of the microneedle;

a posterior surface comprising a first conductive pad; and

a first conductive conduit extending through the first substrate and configured to provide electrical communication between the addressable electrode of a first microneedle of the array of microneedles and the first conductive pad;

a second substrate comprising:

a second conductive pad in electrical communication with the first conductive pad of the first substrate;

a third conductive pad positioned posterior to the second conductive pad; and

a second conductive conduit extending through the second substrate and configured to provide electrical communication between the second conductive pad and the third conductive pad,

wherein a posterior surface of the second substrate comprises a CMOS circuitry transducer; and

a printed circuit board comprising an anterior conductive pad, the anterior conductive pad in electrical communication with the third conductive pad of the second substrate.

2. The device of claim 1 , wherein one or both of the first conductive conduit and the second conductive conduit comprises a through-substrate via.

3. The device of claim 1 , wherein the CMOS circuitry transducer comprises one or more of: a potentiostat, a galvanostat, an analog front end, an amplifier, a filter, an analog-to-digital converter, a microcontroller, and a wireless radio.

4. The device of claim 1 , wherein the first substrate and the second substrate are bonded by solder.

5. The device of claim 1 , wherein the first substrate and the second substrate are bonded by solder and epoxy.

6. The device of claim 1 , wherein the printed circuit board further comprises:

one or more electrical circuit components on a posterior surface of the printed circuit board; and

a through substrate via between the anterior conductive pad of the printed circuit board and the one or more electrical circuit components.

7. The device of claim 6 , wherein the one or more electrical circuit components comprise one or more of a potentiostat, an analog front end, an amplifier, a filter, an analog-to-digital converter, microcontroller, a wireless radio, a battery, and an antenna.

8. The device of claim 1 , wherein the second substrate is bonded to the printed circuit board by stud bumps.

9. The device of claim 1 , wherein the array of microneedles is configured to penetrate a user's skin to access the physiological fluid or tissue.

10. The device of claim 1 , wherein the device is configured to interpret a signal produced by the electrophysiological or electrochemical reaction occurring at the array of microneedles to determine a level of a physiological or biochemical entity.

11. A skin-adorned sensing device comprising:

a die stack mounted on a printed circuit board, the die stack comprising:

a first substrate comprising:

an array of microneedles configured to sense an electrophysiological or electrochemical reaction within physiological fluid or tissue; and

a first conductive conduit in electrical communication with a first microneedle of the array of microneedles and extending through the first substrate; and

a second substrate comprising:

a second conductive conduit extending through the second substrate and longitudinally aligned with the first conductive conduit,

wherein the first conductive conduit and the second conductive conduit are configured to provide electrical communication between the first microneedle of the array of microneedles and the printed circuit board,

wherein a posterior surface of the second substrate comprises a CMOS circuitry transducer; and

wherein the device is configured to interpret a signal produced by an electrophysiological or electrochemical reaction occurring at the first microneedle of the array of microneedles to determine a level of a physiological or biochemical entity.

12. The device of claim 11 , wherein one or both of the first conductive conduit and the second conductive conduit comprise a through-substrate via.

13. The device of claim 12 , wherein the through-substrate via comprises one or more of silicon, germanium, silicon germanium, gallium arsenide, indium phosphide, gallium nitride, zinc oxide, and cadmium selenide.

14. The device according to claim 11 , wherein the printed circuit board comprises electrical circuit components configured to perform the interpreting and the determining, the electrical circuit components comprising one or more of a potentiostat, an analog front end, an amplifier, a filter, an analog-to-digital converter, microcontroller, and a wireless radio.

15. The device of claim 14 , wherein the die stack is mounted to an anterior surface of the printed circuit board, and wherein the electrical circuit components are on a posterior surface of the printed circuit board.

16. The device of claim 15 , wherein an electrical connection between the die stack and the printed circuit board is formed by an anterior conductive pad positioned on the anterior surface of the printed circuit board.

17. The device of claim 14 , wherein the printed circuit board comprises a through-substrate via that provides electrical communication between the die stack and the electrical circuit components.

18. The device of claim 11 , wherein the device is further configured to apply an electrical stimulus to the physiological fluid or tissue to sustain the electrophysiological or electrochemical reaction.

19. A method for quantifying a physiological or biochemical entity in a physiological fluid or tissue, the method comprising:

providing a die stack mounted on a printed circuit board, the die stack comprising:

a first substrate comprising:

an anterior surface comprising an array of microneedles configured to sense an electrophysiological or electrochemical reaction within physiological fluid or tissue; and

a first conductive conduit in electrical communication with a first microneedle of the array of microneedles and extending through the first substrate; and

a second substrate comprising:

a second conductive conduit extending through the second substrate and longitudinally aligned with the first conductive conduit,

wherein the first conductive conduit and the second conductive conduit are configured to provide electrical communication between the first microneedle of the array of microneedles and the printed circuit board, and

wherein a posterior surface of the second substrate comprises a CMOS circuitry transducer;

penetrating a biological interface with the array of microneedles;

routing a signal produced by an electrophysiological or electrochemical reaction within the physiological fluid or tissue from a first microneedle of the array of microneedles to a printed circuit board via the first conductive conduit, the CMOS circuitry transducer, and the second conductive conduit; and

interpreting the signal with the printed circuit board to determine a level of the physiological or biochemical entity.

20. The method of claim 19 , further comprising applying an electrical stimulus to the physiological fluid or tissue with the first microneedle of the array of microneedles.

21. The method of claim 20 , further comprising sustaining the electrophysiological or electrochemical reaction within the physiological fluid or tissue by continuously applying the electrical stimulus.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 25, 2026
From: WINDMILLER, JOSHUA; TANGNEY, JARED RYLAN
To: BIOLINQ INCORPORATED
Reel/Frame 074186/0104 →
CORRECTIVE ASSIGNMENT TO CORRECT THE NAME OF THE ASSIGNEE TO BIOLINQ INCORPORATED IN THE ASSIGNMENT PREVIOUSLY RECORDED ON REEL 56563 FRAME 787. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Mar 25, 2026
From: WINDMILLER, JOSHUA; TANGNEY, JARED RYLAN
To: BIOLINQ INCORPORATED
Reel/Frame 075243/0563 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 16, 2021
From: WINDMILLER, JOSHUA; TANGNEY, JARED RYLAN
To: BIOLINQ, INC.
Reel/Frame 056563/0787 →
Continuity (2)
Continuation 15961793 · Apr 24, 2018
Provisional Application 62492142 · Apr 29, 2017
Cited By (14)
US 1,057,153 US 1,083,640 US 1,083,977 US 1,137,686 US 12,279,888 US 12,285,271 US 12,336,816 US 12,369,830 US 12,453,516 US 12,507,921 US 12,582,337 US 12,599,337 US 12,605,100 US 12,629,060